A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Stopped The study terminated because the clinical development programme for Adavosertib has been discontinued

Conditions

• Advanced Solid Tumours

Interventions

• DRUG: Adavosertib
• DRUG: Itraconazole
• DRUG: Rifampicin
• DRUG: Omeprazole

Sponsor

AstraZeneca

Collaborators

• [object Object]